EagleClaw Capital Managment LLC raised its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 22.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 60,490 shares of the industrial products company’s stock after acquiring an additional 11,035 shares during the quarter. EagleClaw Capital Managment LLC’s holdings in Xylem were worth $6,126,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also modified their holdings of the company. William Mack & Associates Inc. purchased a new position in Xylem during the third quarter valued at $25,000. Dunhill Financial LLC purchased a new stake in Xylem in the second quarter worth about $30,000. Avalon Trust Co purchased a new stake in Xylem in the second quarter worth about $35,000. Orion Capital Management LLC purchased a new stake in Xylem in the second quarter worth about $35,000. Finally, Aventus Investment Advisors Inc. raised its stake in shares of Xylem by 66.7% in the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock worth $35,000 after buying an additional 120 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the stock. BNP Paribas Exane reduced their target price on shares of Xylem from $145.00 to $135.00 and set an “outperform” rating for the company in a report on Wednesday, October 28th. UBS Group lowered their price target on shares of Xylem from $112.00 to $99.00 and set a “neutral” rating on the stock in a report on Thursday, October 29th. Barclays lowered shares of Xylem from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $139.00 to $104.00 in a research report on Wednesday, October 28th. Stifel Nicolaus reduced their price objective on shares of Xylem from $141.00 to $114.00 and set a “buy” rating for the company in a research note on Wednesday, October 28th. Finally, Wolfe Research began coverage on shares of Xylem in a research report on Tuesday, September 15th. They set a “peer perform” rating on the stock. Nine equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $121.31.
Get Our Latest Analysis on Xylem
Xylem News Summary
Here’s some of the latest news about XYL:
- Positive Sentiment: Xylem’s board authorized a new share repurchase program of up to $1.5 billion, effective immediately. The company may buy shares on the open market or in private transactions, depending on market conditions. Buybacks can return capital to shareholders and may support per-share results, though the authorization does not guarantee that the full amount will be spent. Xylem Inc. Announces $1.5 Billion Share Repurchase Authorization
- Positive Sentiment: The company declared a fourth-quarter dividend of $0.43 per share, payable December 22 to shareholders of record November 24. The payout provides a cash return to shareholders; the announcement did not specify a dividend increase. Xylem Declares Fourth Quarter Dividend of 43 Cents per Share
- Positive Sentiment: A November 12 report said Xylem acquired Cornell Pump and Roper Pump, expanding its engineered-pumping portfolio for industrial and municipal markets. The additions could broaden its offerings, although the article provides no deal terms or financial contribution details. Xylem Acquires Cornell Pump and Roper Pump to Expand Portfolio
Xylem Stock Up 0.2%
NYSE XYL opened at $94.21 on Friday. Xylem Inc. has a 12 month low of $87.40 and a 12 month high of $146.76. The company has a current ratio of 1.39, a quick ratio of 1.02 and a debt-to-equity ratio of 0.23. The stock has a market cap of $21.61 billion, a PE ratio of 20.84, a P/E/G ratio of 1.57 and a beta of 1.01. The stock’s 50 day moving average is $102.28 and its 200 day moving average is $115.33.
Xylem (NYSE:XYL – Get Free Report) last announced its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a net margin of 11.94% and a return on equity of 12.06%. The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.28 billion. During the same period last year, the business earned $1.37 earnings per share. The company’s quarterly revenue was down 3.0% compared to the same quarter last year. Research analysts predict that Xylem Inc. will post 5.45 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, Director D Koch bought 11,000 shares of the business’s stock in a transaction that occurred on Thursday, October 29th. The stock was bought at an average cost of $89.60 per share, with a total value of $985,600.00. Following the completion of the purchase, the director owned 12,247 shares of the company’s stock, valued at approximately $1,097,331.20. The trade was a 882.12% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.32% of the company’s stock.
About Xylem
Xylem Inc. is a water technology company that develops equipment, software and services for managing water and wastewater. Its offerings include pumps and treatment systems, water-quality testing and analysis, smart meters, monitoring and control technologies, and services for detecting leaks and maintaining water infrastructure. The company serves water and wastewater utilities, industrial and commercial customers, and residential markets. Its technologies support the movement, treatment, testing and efficient use of water across municipal and industrial systems.
See Also
- Five stocks we like better than Xylem
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
